Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1978 1
1986 1
1988 1
1990 2
1992 3
1994 2
1995 1
1996 4
1997 2
1998 1
1999 8
2000 5
2001 7
2002 3
2003 8
2004 5
2005 7
2006 3
2007 10
2008 12
2009 3
2010 8
2011 15
2012 18
2013 27
2014 18
2015 14
2016 15
2017 11
2018 10
2019 8
2020 10
2021 16
2022 18
2023 10
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
Pan H, Jing H, Yang X, Pan W, Chen T. Pan H, et al. Drug Dev Ind Pharm. 2017 May;43(5):780-788. doi: 10.1080/03639045.2016.1200071. Epub 2016 Jun 29. Drug Dev Ind Pharm. 2017. PMID: 27278057
The combination of metformin hydrochloride (MTF) and glipizide (GLZ) is second-line medication for diabetes mellitus type 2 (DMT2). ...
The combination of metformin hydrochloride (MTF) and glipizide (GLZ) is second-line medication for diabetes mellitus type 2 (D …
Inlay osmotic pump tablets containing metformin and glipizide.
Patel RB, Patel GN, Patel HR, Patel MM. Patel RB, et al. Drug Dev Ind Pharm. 2011 Oct;37(10):1244-52. doi: 10.3109/03639045.2011.567274. Epub 2011 Apr 6. Drug Dev Ind Pharm. 2011. PMID: 21466414
A newly developed inlay osmotic pump tablet (IOPT) can deliver glipizide (GLZ) and metformin HCl (MET) gradually in controlled manner. ...
A newly developed inlay osmotic pump tablet (IOPT) can deliver glipizide (GLZ) and metformin HCl (MET) gradually in controlled …
Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.
Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G; SPREAD-DIMCAD Investigators. Hong J, et al. Diabetes Care. 2013 May;36(5):1304-11. doi: 10.2337/dc12-0719. Epub 2012 Dec 10. Diabetes Care. 2013. PMID: 23230096 Free PMC article. Clinical Trial.
We compared the long-term effects of glipizide and metformin on the major cardiovascular events in type 2 diabetic patients who had a history of coronary artery disease (CAD). ...CONCLUSIONS: Treatment with metformin for 3 years substantially reduced major ca …
We compared the long-term effects of glipizide and metformin on the major cardiovascular events in type 2 diabetic patients wh …
Evaluating gliclazide for the treatment of type 2 diabetes mellitus.
Tomlinson B, Li YH, Chan P. Tomlinson B, et al. Expert Opin Pharmacother. 2022 Dec;23(17):1869-1877. doi: 10.1080/14656566.2022.2141108. Epub 2022 Nov 10. Expert Opin Pharmacother. 2022. PMID: 36300277 Review.
INTRODUCTION: Sulfonylureas have been the standard second-line treatment after failure of metformin monotherapy in patients with type 2 diabetes (T2D) but they are becoming less popular as the newer glucose-lowering agents have a relatively lower risk of hypoglycemia and s …
INTRODUCTION: Sulfonylureas have been the standard second-line treatment after failure of metformin monotherapy in patients with type …
One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.
Campbell IW, Menzies DG, Chalmers J, McBain AM, Brown IR. Campbell IW, et al. Diabete Metab. 1994 Jul-Aug;20(4):394-400. Diabete Metab. 1994. PMID: 7843470 Clinical Trial.
Metformin treated patients lost weight whereas glipizide treated subjects gained weight. ...In conclusion, metformin gave better glycaemic control than glipizide, with weight loss rather than weight gain in obese Type 2 patients....
Metformin treated patients lost weight whereas glipizide treated subjects gained weight. ...In conclusion, metformin ga
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study.
Seck T, Nauck M, Sheng D, Sunga S, Davies MJ, Stein PP, Kaufman KD, Amatruda JM; Sitagliptin Study 024 Group. Seck T, et al. Int J Clin Pract. 2010 Apr;64(5):562-76. doi: 10.1111/j.1742-1241.2010.02353.x. Int J Clin Pract. 2010. PMID: 20456211 Clinical Trial.
OBJECTIVES: To evaluate the 2-year safety and efficacy of adding sitagliptin or glipizide to ongoing metformin in patients with type 2 diabetes. METHODS: Patients who were on a stable dose of metformin (> or = 1500 mg/day) for at least 8 weeks were randomi …
OBJECTIVES: To evaluate the 2-year safety and efficacy of adding sitagliptin or glipizide to ongoing metformin in patients wit …
Simultaneous determination of metformin and glipizide in human plasma by liquid chromatography-tandem mass spectrometry.
Ding CG, Zhou Z, Ge QH, Zhi XJ, Ma LL. Ding CG, et al. Biomed Chromatogr. 2007 Feb;21(2):132-8. doi: 10.1002/bmc.723. Biomed Chromatogr. 2007. PMID: 17221919
A method has been developed for the simultaneous quantification of metformin (I) and glipizide (II) in human plasma. It is based on high-performance liquid chromatography with electrospray ionization tandem mass (LC-ESI-MS/MS) spectrometric detection in positive ion …
A method has been developed for the simultaneous quantification of metformin (I) and glipizide (II) in human plasma. It is bas …
Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.
Cefalu WT, Schneider DJ, Carlson HE, Migdal P, Gan Lim L, Izon MP, Kapoor A, Bell-Farrow A, Terry JG, Sobel BE. Cefalu WT, et al. Diabetes Care. 2002 Dec;25(12):2123-8. doi: 10.2337/diacare.25.12.2123. Diabetes Care. 2002. PMID: 12453948 Clinical Trial.
RESEARCH DESIGN AND METHODS: A total of 91 subjects were screened, subjected to a 4-week drug washout, and randomized to daily treatment with glipizide GITS (maximum 20 mg, n = 46) or metformin (maximum 2,550 mg, n = 45) as monotherapy. ...CONCLUSIONS: When hypergly …
RESEARCH DESIGN AND METHODS: A total of 91 subjects were screened, subjected to a 4-week drug washout, and randomized to daily treatment wit …
Glipizide.
Correa R, Quintanilla Rodriguez BS, Nappe TM. Correa R, et al. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29083816 Free Books & Documents.
Glipizide is a second-generation sulfonylurea that is FDA-approved for the treatment of adults with diabetes mellitus type 2. ...This activity will highlight the indications, mechanism of action, contraindications, adverse event profile, and potential toxicity of glipiz
Glipizide is a second-generation sulfonylurea that is FDA-approved for the treatment of adults with diabetes mellitus type 2. ...This
Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets.
Ouyang D, Nie S, Li W, Guo H, Liu H, Pan W. Ouyang D, et al. J Pharm Pharmacol. 2005 Jul;57(7):817-20. doi: 10.1211/0022357056370. J Pharm Pharmacol. 2005. PMID: 15969939
A simple elementary osmotic pump (EOP) system that could deliver metformin hydrochloride (MT) and glipizide (GZ) simultaneously for extended periods of time was developed in order to reduce the problems associated with multidrug therapy of type 2 non-insulin-depende …
A simple elementary osmotic pump (EOP) system that could deliver metformin hydrochloride (MT) and glipizide (GZ) simultaneousl …
264 results